Cell viability assays showed IC50 cytotoxicity in the 1.1-2.9 μM range and reduced levels of phosphorylated JNK and ATF2 in the T-ALL cell lines JURKAT, KOPT-K1, RPMI-8402, ALL-SIL (67). This evidence concerns the gene MAPK8 and acute lymphoblastic leukemia.